Credit: Original article published here.
In this episode, the Oncology Brothers spoke with world-renowned thoracic oncologist Dr. Jarushka Naidoo of Ireland to learn about her approach for treating me metastatic non-small cell lung cancer (NSCLC) with actionable mutations in the first-line setting. This algorithm is important in the space of thoracic oncology, because as stated by Dr. Naidoo, NSCLC is “the poster child for precision medicine.”
